Karl Strecker - Concepedia

Author

Karl Strecker

Also Known As

K Strecker, K. Strecker, Karl Strecker, Karl Strecker (541933), Katharina Strecker, Kristina Strecker, Strecker, K, Strecker, Karl 1858-1934

184

Publications

Citations

H-Index

Concepts

All Affiliations

Leipzig University Max Planck Institute for Human Cognitive and Brain Sciences University of Tasmania Universitätsmedizin Greifswald Technische Universität Dresden

About

Karl Strecker is an author at Leipzig University specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	391
2	Social Sciences	8	8	367
3	Language Studies	2	2	69
4	Biochemistry	1	1	26
5	Cognitive Science	1	1	51

Karl Strecker

Publications

794

Citations

H-Index

Page 1

	Year	Citations
Adherence to antiparkinson medication in a multicenter European study Donald G. Grosset, Angelo Antonini, Margherita Canesi, Movement Disorders	2009	169
Reduced α4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease Philipp Meyer, Karl Strecker, Kai Kendziorra, Archives of General Psychiatry	2009	154
Impairment of Emotional Facial Expression and Prosody Discrimination Due to Ischemic Cerebellar Lesions Michael Adamaszek, Federico D’Agata, Kenneth C. Kirkby, The Cerebellum NeuropsychologyNeurological DisorderNeuroanatomyAffective NeuroscienceProsody Discrimination Due	2013	83
Preserved serotonin transporter binding in de novo Parkinson’s disease: negative correlation with the dopamine transporter Karl Strecker, Florian Wegner, Swen Hesse, Journal of Neurology Synaptic TransmissionNeurotransmitterNeurotransmissionSocial SciencesNeurology	2010	78
Monoamine transporter availability in Parkinson’s disease patients with or without depression Swen Hesse, Philipp Meyer, Karl Strecker, European Journal of Nuclear Medicine and Molecular Imaging Monoamine Transporter AvailabilityPsychiatric DiseasePsychiatryParkinson DiseaseMonoamine Neurotransmitters	2008	75
An ERP study of vocal emotion processing in asymmetric Parkinson’s disease Patricia Garrido‐Vásquez, Marc D. Pell, Silke Paulmann, Social Cognitive and Affective Neuroscience NeuropsychologyHappy ProsodyNeurolinguisticsAffective NeurosciencePathological Speech	2012	51
Levetiracetam for levodopa-induced dyskinesia in Parkinson’s disease: a randomized, double-blind, placebo-controlled trial Martin Wolz, Matthias Löhle, Karl Strecker, Journal of Neural Transmission Psychotropic MedicationParkinson DiseaseLevodopa-induced DyskinesiaPharmacologyNeuropharmacology	2010	46
Effects of subthalamic nucleus stimulation on striatal dopaminergic transmission in patients with Parkinson’s disease within one-year follow-up Swen Hesse, Karl Strecker, Dirk Winkler, Journal of Neurology Neurobiology Of DiseaseNeurophysiologyMedicineParkinson DiseaseOne-year Follow-up	2008	29
GABAA receptor pharmacology of fluorinated derivatives of the novel sedative-hypnotic pyrazolopyrimidine indiplon Florian Wegner, Winnie Deuther‐Conrad, Matthias Scheunemann, European Journal of Pharmacology Molecular PharmacologyBiochemistryMedicineMechanism Of ActionPharmacological Agent	2007	26
Profound midbrain atrophy in patients with Wilson’s disease and neurological symptoms? Karl Strecker, J.‐P. Schneider, Henryk Barthel, Journal of Neurology Rare DiseasesProfound Midbrain AtrophyNeurological DisorderMedicineDegenerative Disease	2006	21

Page 1